GLMD
Galmed Pharmaceuticals Ltd.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.56
- As of
Share the GLMD intelligence card
See GLMD live in the terminal
Track GLMD's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live GLMD terminal, freeActive signals for GLMD
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 174.8% - EPS $0.29 vs $-0.3876 estimate
- mediumEARNINGS_BEAT
Q1-2025: Beat consensus by 31.7% - EPS $-0.62 vs $-0.9078 estimate
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 25.6% - EPS $-0.63 vs $-0.8466 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 40.1% - EPS $-0.33 vs $-0.5508 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 53.8% - EPS $-0.8 vs $-0.5202 estimate
Top institutional holders of GLMD (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | $84K | 0.00% | +429.0% |
| CITADEL ADVISORS LLC | $71K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LP | $39K | 0.00% | -28.5% |
| TWO SIGMA INVESTMENTS, LP | $29K | 0.00% | , |
| CITADEL ADVISORS LLC | $29K | 0.00% | -24.4% |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, GLMD
- 20-FSEC EDGAR ↗
- 20-FSEC EDGAR ↗
- 20-FSEC EDGAR ↗
Related tickers
Catch the next move on names like this
New 13F filings, insider trades, and cross asset signals like the ones above, in your inbox each morning or live on Telegram. Free, no account.
One email a day. Unsubscribe anytime. We never sell your data.
See more GLMD signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to GLMDand get the insider, 13F, options, and confluence read in one view.